Private Credit Intelligence
The capital structure graph behind private markets. Who lent, to whom, under which sponsor, through which facility, how large the piece was, when it matures and what changed, with a filing behind every number. A BDC piece is that BDC's piece, a sum of pieces is a lower bound, and a sponsor is named with the evidence that names it.
31 borrower groups currently held
A borrower group is every spelling of one credit agreement's borrower across the BDCs that hold it (Icefall Parent, Icefall Topco and Icefall Bidco are one). Grade A and B groups are listed; a short one-word stem (grade C) is kept apart and never merged across filers. Principal is the sum of BDC pieces and is a lower bound.
| Borrower | Sponsor | BDCs | Principal held | On cost | Next maturity | First seen |
|---|---|---|---|---|---|---|
| Mannkind Corporation Biotechnology | unattributed | 3 | at least $228M | 99c | Aug 6, 2030 | Mar 31, 2022 |
| Alcami Corporation Biotechnology | unattributed | 12 | at least $91.1M | 90c | Dec 1, 2028 | Dec 31, 2021 |
| Industria Chimica Emiliana Srl Pharmaceuticals, Biotechnology & Life Sciences | unattributed | 1 | at least $75.5M | 93c | Sep 1, 2028 | Dec 31, 2021 |
| A.T. Holdings II LTD Biotechnology | unattributed | 4 | at least $66.2M | 72c | Sep 13, 2029 | Dec 31, 2022 |
| Nidda Healthcare Holding AG Pharmaceuticals, Biotechnology & Life Sciences | unattributed | 1 | at least $33.0M | 99c | Feb 1, 2030 | Sep 30, 2025 |
| Ranch Bidco B.V Biotechnology · grade B | unattributed | 1 | at least $32.5M | 97c | Jan 28, 2033 | Dec 31, 2025 |
| Life Science Pelthos Therapeutics Inc Biotechnology | unattributed | 1 | at least $30.0M | 100c | Jan 31, 2031 | Mar 31, 2026 |
| Life Science Castle Creek Biosciences Biotechnology | unattributed | 1 | at least $25.5M | 100c | Mar 1, 2028 | Dec 31, 2024 |
| Antheia, Inc Biotechnology Tools · grade B | unattributed | 1 | at least $21.3M | 99c | Aug 1, 2029 | Sep 30, 2025 |
| ADC Therapeutics SA Biotechnology | unattributed | 2 | at least $17.0M | 102c | Aug 15, 2029 | Sep 30, 2022 |
| Life Science KSQ Therapeutics Inc Biotechnology | unattributed | 1 | at least $14.0M | 100c | Apr 1, 2030 | Dec 31, 2024 |
| Rigel Pharmaceuticals Rigel Pharmaceuticals, Inc Biotechnology | unattributed | 1 | at least $13.5M | 100c | Sep 1, 2027 | Dec 31, 2022 |
| Life Science Long Grove Pharmaceuticals Biotechnology | unattributed | 1 | at least $10.5M | 103c | Feb 27, 2031 | Jun 30, 2025 |
| A.T. Holdings II SÀRL Biotechnology | unattributed | 1 | at least $6.7M | 189c | unstated | Sep 30, 2022 |
| Life Science Provivi Biotechnology | unattributed | 1 | at least $6.5M | 61c | Jan 1, 2027 | Dec 31, 2024 |
| iNova Pharmaceuticals Pty Limited Pharmaceuticals, Biotechnology & Life Sciences | Pacific Equity Partners Pty Limited carried | 1 | at least $3.9M | 100c | Nov 1, 2031 | Dec 31, 2022 |
| ALKERMES PLC Biotechnology | unattributed | 1 | at least $130,000 | 101c | Jan 28, 2031 | Mar 31, 2026 |
| Alamar Biosciences, Inc Biotechnology Tools | unattributed | 1 | unknown | n/a | unstated | Dec 31, 2022 |
| Alvotech Holdings S.A Biotechnology | unattributed | 1 | unknown | n/a | unstated | Sep 30, 2022 |
| Bio Vaxys Technology Corp Biotechnology | unattributed | 1 | unknown | n/a | unstated | Dec 31, 2025 |
| Cadrenal Therapeutics Inc Biotechnology | unattributed | 1 | unknown | n/a | unstated | Dec 31, 2025 |
| Castle Creek Biosciences Inc Biotechnology | unattributed | 1 | unknown | n/a | unstated | Dec 31, 2025 |
| Emalex Biosciences Inc Biotechnology | unattributed | 1 | unknown | n/a | unstated | Dec 31, 2025 |
| Evelo Holdings Inc Biotechnology · grade B | unattributed | 1 | unknown | n/a | unstated | Dec 31, 2025 |
| Fortress Biotech, Inc Biotechnology | unattributed | 1 | unknown | n/a | unstated | Sep 30, 2022 |
| Life Science Emalex Biosciences Inc Biotechnology | unattributed | 1 | unknown | 100c | May 1, 2026 | Dec 31, 2024 |
| Mesoblast, Inc Biotechnology | Novaquest Capital Management, L.L.C. carried | 2 | unknown | n/a | unstated | Sep 30, 2022 |
| Partner Therapeutics, Inc Biotechnology | unattributed | 1 | unknown | n/a | unstated | Mar 31, 2022 |
| PathAI, Inc Biotechnology Tools · grade B | unattributed | 1 | unknown | n/a | unstated | Dec 31, 2022 |
| Seres Therapeutics, Inc Biotechnology | unattributed | 3 | unknown | n/a | unstated | Sep 30, 2022 |
| Sorrento Therapeutics, Inc Biotechnology | unattributed | 1 | unknown | n/a | unstated | Sep 30, 2022 |
Principal and marks are the filers' figures at each BDC's latest quarter end, summed. Maturity is the filer's tagged date or the date written into the identifier; a BDC that tags neither leaves it unstated.